FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称PINATUZUMAB VEDOTIN
异名/同义词ACD22-VCMMAE
ACD-22VCMMAE
ACD-22-VCMMAE
ANTI-CD22-MONOMETHYL AURISTATIN E ANTIBODY-DRUG CONJUGATE
FCU2703
FCU-2703
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS CD22 (SIALIC ACID BINDING IG-LIKE LECTIN 2, SIGLEC2, SIGLEC-2, BLYMPHOCYTE CELL ADHESION MOLECULE, BL-CAM, LEU-14)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E
PINATUZUMAB VEDOTIN
PINATUZUMAB VEDOTIN [INN]
PINATUZUMAB VEDOTIN [USAN]
PINATUZUMAB VEDOTIN [WHO-DD]
RG-7593
RO5541072-000
RO-5541072000
RO-5541072-000
DCDT2980S
DCDT-2980S
CAS登记号1313706-14-7
物质唯一标识(Unique Ingredient Identifier)6KA1906BLC
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System